...
首页> 外文期刊>Neuromuscular disorders: NMD >Interfamilial phenotypic heterogeneity in SMARD1.
【24h】

Interfamilial phenotypic heterogeneity in SMARD1.

机译:SMARD1中的家族间表型异质性。

获取原文
获取原文并翻译 | 示例
           

摘要

Spinal muscular atrophy with respiratory distress (SMARD1: mu-binding protein 2 gene mutation) is characterised by low birth weight, progressive distal limb weakness, diaphragmatic paralysis and subsequent respiratory failure manifesting before 13 months of age. Our case report illustrates marked phenotype variability in two siblings with an identical genetic mutation of SMARD1, one of whom died of fulminant respiratory failure aged 6 months, whereas the other shows limb weakness but, only mild sleep hypoventilation aged 12 years. This suggests other compensatory mechanisms may play a role in modifying SMARD1; broadening our perception of phenotype. Therefore, SMARD1 phenotype should be considered in cases of atypical spinal muscular atrophy even in the absence of overt diaphragmatic weakness.
机译:患有呼吸窘迫的脊髓性肌萎缩症(SMARD1:mu-binding protein 2基因突变)的特征是出生体重低,四肢进行性远端四肢无力,diaphragm肌麻痹以及随后的13个月前出现呼吸衰竭。我们的病例报告说明了具有相同SMARD1基因突变的两个兄弟姐妹明显的表型变异,其中一个死于6个月大的呼吸衰竭,而另一个死于肢体无力,但只有轻度的睡眠低通气,年龄12岁。这表明其他补偿机制可能在修饰SMARD1中起作用。拓宽了我们对表型的认识。因此,即使在没有明显的diaphragm肌无力的情况下,在非典型脊柱肌萎缩的情况下也应考虑SMARD1表型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号